Pfizer Inc (NYSE:PFE)
| 51.55 Delayed Data As of Jan 24 |  +0.01 / +0.02%Today’s Change | 33.36 Today|||52-Week Range 61.71 | -12.70% Year-to-Date |
PFE Regular Dividend: PFE will begin trading ex-dividend on 01/27/22 with a $0.40 dividend payable to shareholders of record as of 01/28/22.
Latest PFE News | Press Releases
Today’s Trading
| Previous close | 51.54 |
| Today’s open | 51.73 |
| Day’s range | 49.82 - 52.06 |
| Volume | 9,634 |
| Average volume (3 months) | 37,973,911 |
| Market cap | $296.3B |
Data as of 5:54pm ET, 01/24/2022
Growth & Valuation
| Earnings growth (last year) | -40.76% |
| Earnings growth (this year) | +89.46% |
| Earnings growth (next 5 years) | +16.47% |
| Revenue growth (last year) | -19.02% |
| P/E ratio | 15.0 |
| Price/Sales | 4.95 |
| Price/Book | 4.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -0.04 | -0.03% |
| LLYEli Lilly and Co | +0.29 | +0.12% |
| MRKMerck | +0.02 | +0.03% |
| NVSNovartis | -0.04 | -0.05% |
Data as of 5:52pm ET, 01/24/2022
Financials
| Next reporting date | February 8, 2022 |
| EPS forecast (this quarter) | $0.86 |
| Annual revenue (last year) | $41.9B |
| Annual profit (last year) | $9.6B |
| Net profit margin | 16.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
